New Report Details State of Rare Disease R&D, Investment and Treatment

ALISO VIEJO, Calif.–(BUSINESS WIRE)–Global Genes, a leading rare disease patient advocacy organization, today released its NEXT 2022: Redefining the Possible report, an annual reflection on the status of innovation and progress in rare diseases, including a comprehensive collection of data, studies and key findings published throughout 2021 from leading global…